Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2245035 in mild allergic asthma
NCT02833974Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GSK2245035 in allergic asthma, sponsored by GSK. Started Dec 2016; status: completed.
02
Drugs
GSK2245035
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT02833974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02833974.